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Accumulation of activated neutrophils at the feto-maternal interface is a defining hallmark
of intrauterine inflammation (IUI) that might trigger an excessive immune response during
pregnancy. Mechanisms responsible of this massive neutrophil recruitment are poorly
investigated. We have previously showed that intraamniotic injection of LPS in rhesus
macaques induced a neutrophil predominant inflammatory response similar to that seen
in human IUI. Here, we demonstrate that anti-TNF antibody (Adalimumab) inhibited
∼80% of genes induced by LPS involved in inflammatory signaling and innate immunity
in chorio-decidua neutrophils. Consistent with the gene expression data, TNF-blockade
decreased LPS-induced neutrophil accumulation and activation at the feto-maternal
interface. We also observed a reduction in IL-6 and other pro-inflammatory cytokines
but not prostaglandins concentrations in the amniotic fluid. Moreover, TNF-blockade
decreased mRNA expression of inflammatory cytokines in the chorio-decidua but not
in the uterus, suggesting that inhibition of TNF-signaling decreased the inflammation in
a tissue-specific manner within the uterine compartment. Taken together, our results
demonstrate a predominant role for TNF-signaling in modulating the neutrophilic
infiltration at the feto-maternal interface during IUI and suggest that blockade of
TNF-signaling could be considered as a therapeutic approach for IUI, the major leading
cause of preterm birth.
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INTRODUCTION
About 25–40% of preterm births (PTB) are associated with
intrauterine infection (IUI) (1) and other studies suggest that
inflammation is implicated in as many as 90% of very early
PTB (2). Importantly, the causal link between IUI and PTB is
well-established (3). Currently, the rate of prematurity remains
stubbornly high at about 10% of all US births (4). Further, about
75% of perinatal mortality and 50% of the long-term childhood
morbidity is directly attributable to prematurity (1). Apart from
maternal morbidity, IUI causes fetal inflammation and increases
the risk for fetal and newborn brain, gut, and lung injury in both
clinical studies and in animal models [reviewed in (5)].
The histologic correlate of IUI is chorioamnionitis, defined
as neutrophilic infiltration of the placenta, fetal membranes,
and the amniotic fluid (6, 7). During IUI, neutrophils are the
most abundant leukocyte, and are activated to secrete pro-
inflammatory mediators (8–11). In contrast, small numbers of
neutrophils are present in the chorio-decidua during normal
gestation (12, 13). The roles of neutrophils in the chorio-
decidua during normal pregnancy and IUI are not known. Thus,
neutrophil function at the maternal-fetal interface during normal
pregnancy and in pathologic inflammatory conditions needs
further investigation to improve our understanding of normal
and preterm labor.
Tumor necrosis factor α (TNFα) is implicated in IUI
and PTB in clinical studies and animal experiments (14–16).
Intra-amniotic (IA) injection of LPS in the rhesus macaque
induced neutrophil infiltration of the chorio-decidua and
increased neutrophil TNF expression in neutrophils (8, 10).
Furthermore, IA infusion of TNFα alone induced intrauterine
inflammation, neutrophil recruitment and preterm labor in
rhesus macaques (17).
We therefore hypothesized that TNF-signaling was a major
mediator of intrauterine inflammation. Our objective was to
understand the role of TNF-signaling and particularly as it relates
to neutrophils’ recruitment and function during IUI. We tested
this hypothesis in a rhesus macaque model of IUI induced by
IA LPS, which was previously demonstrated to resemble human
chorioamnionitis (10). TNF-signaling was inhibited by the anti-
TNF antibody (Adalimumab—human IgG) used clinically to
inhibit TNF in inflammatory diseases (18).
MATERIALS AND METHODS
Animals
Normally cycling, adult female rhesus macaques (Macaca
mulatta) (n = 56) were time mated. At ∼130 d of gestation
(∼80% of term gestation), the pregnant rhesus received either
a 1ml saline solution (n = 26, two control animals received
intramuscular instead of IA saline) or 1mg LPS (Sigma-Aldrich,
St. Louis, MO, n = 19) in 1ml saline solution by ultrasound-
guided intraamniotic (IA) injection. Tumor necrosis factor
(TNF) signaling was inhibited in the amniotic and systemic
compartments by the TNF blocker Adalimumab (Humira,
AbbVie Inc. North Chicago, IL) given IA (40mg) + maternal
subcutaneous (s.c.) (40mg) 1 and 3 h before LPS, respectively
(n = 11) (Supplementary Figure 1). Fetuses were surgically
delivered 16 h after LPS-exposure. This timing was determined
to be the optimum time point based on our previous studies
(10, 19). Themultiparousmacaques and their fetuses were similar
in clinical variables (Supplementary Table 1). After delivery,
fetuses were euthanized with pentobarbital, and fetal tissues were
collected. There were no spontaneous deaths or preterm labor in
the animals. The relatively large sample size was made possible
by using tissues from animals used in a previous study (older
samples) (10); Control (n = 16) and LPS exposed animals (n
= 13) in addition to new animals: Controls (n = 10), LPS-
exposed animals (n = 6), and Adalimumab-treated animals (n
= 11) for the current study. It was not always possible to obtain
all the tissues/fluids from each animal. The numbers of animals
for each experiment are shown in the corresponding figure. All
assays using older and newer samples were run at the same time.
Comparison of data using older animals (tissues preserved longer
in freezers) with the newer animals yielded similar results (not
shown), and thus the combined data are shown. We confirmed
bioavailability of specific TNF inhibitory activity in the amniotic
fluid (AF) at 16 h (Supplementary Figure 2).
Chorion-Amnion-Decidua Dissection
Extra-placental membranes were collected immediately after C-
section and were dissected away from the placenta, as previously
described (8, 10). After scraping decidua parietalis cells with the
attached chorion, the amnion and rest of the chorion tissue were
peeled away from each other with forceps. Chorio-decidua cells
were washed, and digested with Dispase II (Life Technologies,
Grand Island, NY) plus collagenase A (Roche, Indianapolis, IN)
followed by DNase I (Roche) treatment, as previously described
(8, 10). Cell suspensions were filtered, the red blood cells lysed
and prepared for flow cytometry or FACS-sorting (10). Viability
was>90% by trypan blue exclusion test.
Flow Cytometry of Chorio-Decidua Cells
Monoclonal antibodies (mAbs) used for multiparameter flow
cytometry (LSR Fortessa 2, BD Biosciences, San Diego, CA)
are listed in the Supplementary Table 2. Gating strategy to
identify the different leukocyte subpopulations was done as
previously described (10). Cells were treated with 20µg/mL
human immunoglobulin G (IgG) to block Fc receptors, stained
for surface markers for 30min at 4◦C in PBS, washed, and fixed
in fixative stabilizing buffer (BD Bioscience). For detection of
reactive oxygen species (ROS), 1× 106 chorio-decidua cells were
loaded with 2.5µM of Dihydrorhodamine123 (DHR, Molecular
Probes, Eugene, OR) in DMSO or DMSO (as control). Cells were
incubated at 37◦C for 15min. Following incubation, the samples
were stained with a cocktail of mAbs (Supplementary Table 2) at
room temperature in the dark for 30min. Samples were acquired
within 30min after the staining and DHR MFI from neutrophils
were compared to that of lymphocytes that lack this enzyme
system activity (negative controls). All antibodies were titrated
for optimal detection of positive populations and similar mean
fluorescence intensity. At least 500,000 events were recorded for
each sample. Doublets were excluded based on forward scatter
properties, and dead cells were excluded using LIVE/DEAD
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Fixable Aqua dead cell stain (Life Technologies). Unstained and
negative biological population were used to determine positive
staining for each marker. Data were analyzed using FlowJo
version 9.5.2 software (TreeStar Inc., Ashland, OR).
Neutrophil Isolation
Maternal peripheral blood samples were collected 30min before
delivery from the same animals that the fetal membranes
were collected. Blood neutrophils were isolated using human
MACSxpress neutrophil isolation kit (Miltenyi Biotec, Auburn,
CA). Neutrophil purity was>97%, as assessed by flow cytometry
and Diff-Quick (Electron Microscopy Sciences, Hatfield, PA)
staining of cytospin slides (Supplementary Figure 3). Chorio-
decidua neutrophils cells were purified from chorio-decidua cell
suspension by FACSAria Cell Sorter (BD Bioscience), using
the same gating strategy as for immunophenotyping described
previously (10). FACS-sorted chorio-decidua neutrophil purity
was >97% (Supplementary Figure 4), as assessed by Diff-Quick
staining. Total RNA was extracted from the purified neutrophils
(2–4 × 106) by adding TRIzol (ThermofisherScientific) and
subsequently using Direct-Zol RNA MicroPrep kit (ZYMO
Research, Irvine, CA) to efficiently extract small quantities
of RNA.
RNA Extraction and qPCR
Total RNA was extracted from fresh bead-sorted maternal blood
neutrophils, FACS-sorted chorio-decidua neutrophils, snap-
frozen chorioamnion-decidua, fetal lung, uterus, and amnion,
after homogenizing in TRIzol (Invitrogen, Carlsbad, CA).
RNA concentration and quality were measured by Nanodrop
spectrophotometer (Thermo-Scientific). Reverse transcription
of the RNA was performed using Verso cDNA synthesis
kit (Thermo-Scientific). Quantitative RT-PCR was carried out
in a StepOnePlus real-time PCR system (Life Technologies)
following standard cycling conditions. Quantitative RT-PCR
(qPCR) assays were performed with Rhesus-specific TaqMan
gene expression primers (Life Technologies). A list of probes is
provided in Supplementary Table 3. Eukaryotic 18S rRNA (Life
Technologies) was the endogenous control for normalization of
the target RNAs, and a sample from an IA saline injected rhesus
animal was used to calibrate. The values were expressed relative
to the average value of the control group.
RNA Sequencing and Analysis
The integrity of purified total RNA from bead-isolated maternal
blood neutrophils and FACS-sorted chorio-decidua neutrophils
was assessed using HighSensitivity RNA ScreenTapes on the
TapeStation 2200 (Agilent Technologies). Ten to fifty nanogram
of starting material were used as input material for the NEBNext
rRNA Depletion kit (cat# E6350). RNA libraries were then
prepared using the NEBNext Ultra II RNA kit (cat# E7765).
Quality control for each final library was performed using a
D1000 ScreenTape (TapeStation 2200–Agilent Technologies) and
quantified using a Qubit dsDNA BR Assay (Life Technologies).
Diluted libraries were pooled and sequenced 50 single-end on a
HiSeq3000 (Illumina). The reads were mapped with STAR 2.5.3a
to the Macaca mulatta genome (Mmul 8.0.1). The counts for
each gene were obtained by using quantMode GeneCounts in the
STAR commands, and only counts for the featured genes were
reserved. Differential expression analyses were carried out using
DESeq2. The normalized counts were obtained from the DESeq2
analysis. Principal Component Analysis (PCA) were performed
on the normalized counts using the open-source software
AltAnalyze (http://www.altanalyze.org/). Volcano plots were
made for the results from the differential expression analyses.
Heatmaps were plotted on the log2 value of the normalized
counts. Inference of biological processes were generated using
Enrichr (20).
To determine maternal or fetal origin of chorio-decidua
neutrophils, we used RNA-seq data from maternal blood
neutrophils for maternal genotype and fetal lung for fetal
genotype. We systemically scanned the entire RNA-seq data for
sequences that were divergent between the mother and the fetus
by aligning the bam files for fetal lung and maternal blood.
We identified at least 5 such informative SNP divergence in
genes with high expression in each mother-fetus pair (n =
3). The corresponding SNPs were compared between maternal
neutrophils, fetal lung, and chorio-decidua neutrophils in the
integrative genomics viewer (IGV). Final data were presented as
number of reads and converted to frequency of nucleotides at
each of the informative SNPs.
All original RNAseq data were deposited in the NCBI’s Gene
Expression Omnibus database (GEO accession: GSE145918).
Cytokines and Prostaglandins ELISA
Cytokine/chemokine concentrations in amniotic fluid (AF), fetal,
and maternal plasma were determined by Luminex using non-
human primate multiplex kits (Millipore). Lipids were extracted
from theAF usingmethanol and ELISA kits were used tomeasure
Prostaglandins PGE2 (Oxford Biomedical Research, Oxford, MI)
and PGF2α (Cayman Chemical, Ann Arbor, MI) concentrations.
TNF Bio-Activity Experiments
Hek-Dual TNFα cells (Invivogen) derived from the human
embryonic kidney 293 cell line by stable co-transfection of
two NF-kB-inducible reporter constructs: the SEAP (secreted
embryonic alkaline phosphatase) gene and the Lucia luciferase
gene were used. Both reporter genes are under the control
of the same NF-KB-inducible promoter. In this system, the
cells specifically respond to TNF and not to other TLR/IL1
signals since they lack intracellular MyD88. Hek-Dual TNFα cells
were stimulated over night with rTNFα (4 ng/ml, Peprotech)
with or without the addition of amniotic fluid (AF) (dilution
1:10) obtained at delivery from Control (Ctrl) or Adalimumab
injected animals. The presence or inhibition of bioactive TNFα
was demonstrated by activation/inhibition of the AP-1/NF-KB
pathway using QUANTI-Blue Solution (Invivogen) resulting in
luciferase bio-luminiscence.
Statistics
Prism version 5.0b software (GraphPad) was used to analyze
data. Values were expressed as means± SEM. Two-tailed Mann-
Whitney U-tests and Unpaired t-test were used to determine
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differences between groups. Results were considered significant
for P ≤ 0.05.
Study Approval
All animal procedures were approved by the IACUC at UCDavis,
California Primate Center.
RESULTS
LPS-Exposure Induced a Neutrophil
Predominant Immune Cell Infiltration of the
Chorio-Decidua
During IUI, the chorio-decidua is the tissue with the highest
infiltration of leukocytes at the feto-maternal interface
(8, 10). Chorio-decidua immune cell profiling revealed
that macrophage and NK cells were the most abundant
leukocytes in controls, while neutrophils were the most
abundant leukocytes in the chorio-decidua upon LPS-
exposure (Figure 1A, Supplementary Figure 5). Adalimumab
partially restored the chorio-decidua immune cell profile
similar to controls (Figure 1A, Supplementary Figure 5).
Besides neutrophils, LPS increased B cell counts and
Adalimumab treatment reversed the B cell increases
(Supplementary Figure 5).
Blood vs. Chorio-Decidua Neutrophil
Transcriptomes Differ Significantly
To determine the gene expression profile of the infiltrating
neutrophils after LPS-exposure, we analyzed comparative
gene expression profiles of blood and chorio-decidua
neutrophils in controls and experimental animals. We first
compared transcriptomic profiles from purified maternal blood
neutrophils and FACS-sorted chorio-decidua neutrophils.
Unbiased principal component analysis (PCA) of global
gene-expression profiles demonstrated distinct clustering
of blood vs. chorio-decidua neutrophils independent of
prenatal exposures (Figure 1B), indicating that tissue of origin
rather than treatments was a more important determinant
of neutrophil gene-expression. In our model of localized
intrauterine inflammation, maternal blood neutrophil gene
expression profile did not differ significantly after IA LPS-
exposure (Supplementary Figure 6) (also note similar PCA
distribution between control and experimental blood neutrophil
samples indicated in open circles in Figure 1B). Therefore, to
better define gene signatures of chorio-decidua neutrophils,
we restricted comparisons of chorio-decidua vs. blood
neutrophils to control animals. Heat-maps of differentially
expressed genes show distinct expression profiles in blood
vs. chorio-decidua neutrophils (Figure 1C). Importantly, the
replicates within each group were similar, demonstrating
consistency of the findings. Functional annotations of
differentially expressed genes predicted upregulation of
the extracellular matrix organization, positive regulation
of cell migration, regulation of apoptotic processes, and
endothelial cell migration in the chorio-decidua compared
to blood neutrophils (representative genes ICAM5, VEGFA,
FASLG, NR4A1) (Figures 1D,E, Supplementary Figure 7A
showing expanded list of representative genes for different
pathways). Pathways predicted to be down-regulated in
chorio-decidua were neutrophil-mediated immunity, type-I
interferon signaling pathway, and toll-like receptor signaling
(representative genes CD300A, IRF2, TLR10) (Figures 1D,E,
Supplementary Figure 7B showing additional representative
genes for different pathways). Notably, the pair-wise comparison
of tissue vs. blood neutrophil was done using the same control
animal lending additional validity to the analyses.
Distinct Transcriptional Profiles in
Chorio-Decidua Neutrophils Upon
LPS-Exposure and TNF-Blockade
In contrast to blood neutrophils, PCA of global gene-expression
profiles of FACS-sorted chorio-decidua neutrophils segregated
according to prenatal exposures (Figure 2A). Heat-maps of
differentially expressed genes were similar within each group
and demonstrated distinct expression profiles in control vs.
LPS-exposed neutrophils with an intermediate profile after
TNF-blockade (Figure 2B). Comparison of LPS-exposed vs.
control chorio-decidua neutrophils revealed 535 differentially
expressed genes (418 upregulated, 117 downregulated),
while 178 genes were differentially expressed in LPS vs.
Adalimumab groups (Figures 2C,D). For further insight
into the mechanisms of neutrophil activation during IUI,
we focused on genes robustly induced after LPS (Base Mean
>10 and fold change ≥4). Compared to control neutrophils,
LPS-exposure upregulated a total of 325 transcripts (Figure 2E).
Of these 325 LPS-induced genes, 255 genes were inhibited
by Adalimumab (designated as “TNF-dependent genes”)
(Base Mean > 10; fold decrease ≥ 1.5 in Adalimumab
vs. LPS), 55 genes did not change their expression upon
Adalimumab treatment (Base Mean > 10; fold change ↓1.5 <
x < ↑1.5, “TNF-independent genes”) (Figure 2E), and only 15
genes were further up-regulated by Adalimumab (Figure 2E,
Supplementary Table 4).
Functional annotations of LPS-upregulated TNF-dependent
genes predicted alterations in the following biological
processes (representative gene): inflammatory response (IL6),
neutrophil-mediated immunity (LCN2), cytokine-mediated
signaling pathway (IL1A), apoptotic processes (BCL2L14),
and toll-like receptor signaling (NFkB1) (Figures 3A,B,
Supplementary Figure 8A, Supplementary Table 5). These
findings were further validated by quantitative PCR (qPCR)
analysis of a few selected key genes (e.g., IL6, NFKB1, LCN2:
Figure 3C, and TNF: Supplementary Figure 8B–due to
paucity of FACS-sorted neutrophil RNA, more extensive
validation could not be performed). On the other hand,
functional annotations of LPS-upregulated TNF-independent
genes predicted changes in a number of biological processes
including: negative regulation of signal transduction (DKK1,
SOCS3, CISH), regulation of extracellular matrix organization
(DDR2), positive regulation of cell migration (PDPN2,
SYDE1), linoleic acid metabolic process (FADS1, FADS2)
(Supplementary Figures 9A,B).
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FIGURE 1 | Changes in the global transcriptional landscape of chorio-decidua neutrophils compared to blood neutrophils. (A) Chorio-decidua cells were scraped,
digested with protease/DNAase and single cell suspensions were used for multiparameter flow cytometry phenotyping. CD45+ subsets showed a neutrophil
(Continued)
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FIGURE 1 | predominance after LPS (n = 19), while Adalimumab treatment (n = 11) partially restored the profile toward controls (n = 18). (B) Principal-component
analysis (PCA) of RNA-seq profiling of neutrophils isolated from maternal blood using magnetic beads (open circles: Ctrl n = 3; LPS n = 5; Adalimumab n = 3) and
from chorio-decidua by FACS (full circles: Ctrl n = 3; LPS n = 5; Adalimumab n = 4). The expression values were normalized across the entire datasets. (C) Heatmap
of genes that are differentially expressed genes (DEGs, adjusted p < 0.05) between blood (n = 3) and chorio-decidua neutrophils (n = 3) in control animals only. (D)
Biological processes of differentially expressed genes shown in (C), as determined by Enrichr. Black bars represent upregulated biological processes and open bars
represent downregulated biological processes in chorio-decidua neutrophils vs. blood neutrophils from control animals only. (E) Normalized counts of gene expression
value of representative genes associated with the biological processes depicted in (D). The lines show normalized counts of gene-expression trend plot from the same
control animal (black line= sample #427, red line = sample #432, green line = sample #430; n = 3). *p < 0.05 (Unpaired t-test).
FIGURE 2 | Profound changes in the global transcriptional landscape of chorio-decidua neutrophils upon different treatments. (A) Principal-component analysis of
RNA-seq data from FACS-sorted chorio-decidua neutrophils of control (Ctrl) (green dots; n = 3), LPS (red dots; n = 5), and Adalimumab animals (blue dots; n = 4)
showing distinct clustering based on exposures. (B) Heatmap of genes that are differentially expressed (DEGs) between chorio-decidua neutrophils upon different
treatments showing minimal inter-animal variability within each group (Ctrl n = 3; LPS n = 5; Adalimumab n = 4). (C,D) Volcano plots displaying differentially expressed
genes. Red dots and numbers indicate genes with an FDR-adjusted value < 0.05. (E) Pie chart shows 325 genes that are induced by LPS (≥4-fold change vs. ctrl).
Of those 325 genes, 225 genes are downregulated by Adalimumab (↓ ≥1.5-fold change vs. LPS, “TNF-dependent genes”), 55 do not change their expression upon
Adalimumab treatment (↓1.5 < x< ↑1.5-fold change vs. LPS, “TNF-independent genes”), and 15 genes are upregulated by Adalimumab (≥↑1.5-fold change vs. LPS).
Adalimumab Blocks Neutrophil Activation
in Chorio-Decidua
We further validated genomic predictions of TNF-blockade of
LPS-induced chorio-decidua neutrophil inflammatory pathways
with biological measurements. LPS-exposure significantly
increased the frequency of neutrophils (Figure 4A), the
production of reactive oxygen species (ROS) in neutrophil
as demonstrated by Dihydrorhodamine 123 (DHR) uptake
(Figure 4B, Supplementary Figure 10A), and the expression
of CD63, a marker for release of azurophilic granules (21)—
(Figure 4C, Supplementary Figure 10B), and CD16 (FCRγIII)
expression (22) (Figure 4D, Supplementary Figure 10C).
Adalimumab efficiently reduced LPS-induced increases in
frequency, ROS production, CD63/CD16 expression in chorio-
decidua neutrophils, suggesting that TNF-signaling regulates
the activation of neutrophils in the setting of IUI. In line
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FIGURE 3 | TNF-signaling inhibition decreased neutrophil mediated immunity. (A) Biological processes of LPS-induced genes (≥4-fold vs. controls) that were
significantly down-regulated by Adalimumab (≥1.5-fold decrease vs. LPS) designated as “TNF-dependent genes,” determined using Enrichr. Dotted line represents
gene-expression values representing the mean of three control animals. (B) Representative genes representing biological processes inhibited by Adalimumab shown
in (A) (dotted-line represents the mean of 3 Ctrl; LPS n = 5; Adalimumab n = 4). (C) Validation of selected transcript expression by qPCR analysis. mRNAs were
isolated from FACS-sorted chorio-decidua neutrophils from Ctrl (dotted-line represents the mean of 3 Ctrl), LPS- (n = 4–5), and Adalimumab-treated animals (n = 4).
qPCR was performed using rhesus-specific Taqman probes. The values were first internally normalized to the endogenous 18S RNA. For each gene, the box plot
(median and 5–95th percentile and outliers) shows fold-change of gene expression in chorio-decidua neutrophils normalized to control chorio-decidua neutrophils
(dotted-line represents the mean of 3 ctrl). *p < 0.05 vs. ctrl; #p<0.05 vs. LPS (Mann–Whitney U-test).
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FIGURE 4 | Adalimumab decreased LPS-induced chorio-decidua neutrophil accumulation and activation. Chorio-decidua cells were scraped and digested with
protease/DNAase, and single cell suspensions were used for multiparameter flow cytometry. Neutrophils were defined as CD45+CD3−CD14lowHLADR-CD88+
CD56− cells. Inhibition of TNF-signaling by Adalimumab decreased significantly neutrophil frequency (Ctrl n = 19; LPS n = 19; Adalimumab n = 10) (A), neutrophil
reactive oxygen species production measured by Dihydro-rhodamine (DHR) fluorescence (Ctrl n = 5; LPS n = 5; Adalimumab n = 6) (B), CD63 expression, a marker
of degranulation of azurophilic granules (Ctrl n = 12; LPS n = 14; Adalimumab n = 10) (C), and expression of FCγIII receptor CD16 (Ctrl n = 12; LPS n = 14;
(Continued)
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FIGURE 4 | Adalimumab n = 10) (D). Data are mean ± SEM, *p < 0.05 between comparators by Mann-Whitney U-test. (E) Adalimumab decreased significantly the
expression of genes associated with neutrophil chemotaxis. The box plot shows fold-change of gene expression in chorio-decidua neutrophils normalized to control
chorio-decidua neutrophils (dotted-line represents the mean of 3 Ctrl; LPS n = 5; Adalimumab n = 4). *p <0.05 vs. ctrl; #p <0.05 vs. LPS (Mann–Whitney U-test). (F)
Frequency of nucleotides in SNPs in the fetal lung (representing fetal genome), chorio-decidua neutrophils, and maternal blood neutrophils (representing maternal
genome) at five different informative loci in each mother-infant pair (total n = 3). Note similar frequency distribution of nucleotides at each of the SNPs in maternal
blood neutrophils and chorio-decidua neutrophils and divergence compared to the fetal lung. For each SNP the chromosomal location and the encoded gene is
shown. The frequency of nucleotides was computed at each SNP based on the number of reads shown in Supplementary Table 6.
with these results, Adalimumab also significantly reduced the
expression of ITGAM (CD11b), ITGB2 (CD18), and CCL3,
suggesting that neutrophil chemotaxis is also regulated by
TNF-signaling (Figure 4E). This finding is consistent with a
previous study demonstrating that TNFα induced neutrophil
migration through upregulation of integrin CD11b/CD18
and CCL3 (23).
To gain further insights into maternal vs. fetal origin of
chorio-decidua neutrophils responding to LPS and TNF-
signaling, we compared genotypes of the informative SNPs
in three different mother-infant pairs (one each from the
three groups). The nucleotide frequencies in each of the
informative SNPs in all of the animals were almost identical
in the maternal blood neutrophils and chorio-decidua
neutrophils (Figure 4F and the corresponding reads shown
in Supplementary Table 6). In comparison, fetal lung genotype
showed a divergence in the nucleotide frequency indicating
that the chorio-decidua neutrophils were almost entirely of
maternal origin (Figure 4F and the corresponding reads shown
in Supplementary Table 6).
Adalimumab Blocks Inflammation in
Chorioamnion-Decidua
To understand if TNF-blockade of chorio-decidua neutrophil
accumulation and activation was also associated with generalized
anti-inflammatory effects, inflammatory mediators were assessed
in multiple maternal-fetal compartments. LPS increased mRNAs
for IL1β (200-fold), IL6 (6-fold), IL8 (150-fold), TNFα
(30-fold), and CCL2 (12-fold) in the chorioamnion-decidua
tissue (Figure 5). Adalimumab broadly decreased LPS-induced
increases in inflammatory mediators in the chorioamnion-
decidua (Figure 5).
Amnion Participation in IUI
It is unknown which of the resident tissues/cells at the
maternal-fetal interface are responsible for neutrophil
recruitment. Recently, we showed that the amnion, the
tissue in contact with the amniotic fluid participates
in recruiting neutrophils upon LPS injection into the
amniotic fluid (10). Herein, we confirmed and expanded
our previous results showing large increases in cytokine
mRNAs including neutrophil chemotactic factors IL8/CXCL8
and CSF3 detected upon LPS-exposure in the amnion
(Figure 6). Adalimumab significantly decreased LPS-
induced increases in inflammatory mediators in the amnion
(Figure 6).
Adalimumab Blocks Inflammation in
Amniotic Fluid, but Not in the Uterus
IA LPS-exposure significantly increased pro-and anti-
inflammatory cytokines (IL-1β, IL-6, TNFα, IL-1ra, IL-10,
and GM-CSF), chemokines (IL-8/CXCL-8, CCL2/MCP-1, and
CCL4/MIP1β) and prostaglandins (PGF2α and PGE2) in the
amniotic fluid (AF) (Figure 7A). LPS-exposure also significantly
increased the frequency of neutrophils in AF (Figure 7B).
Adalimumab broadly decreased LPS-induced increases in
pro- and anti-inflammatory cytokines in the AF except IL-1β
and GM-CSF (Figure 7A). TNF-blockade also decreased the
frequency of neutrophils in AF (Figure 7B), but did not decrease
LPS-induced increases in prostaglandins in the AF (Figure 7A).
LPS increased mRNAs for IL1β (150-fold), IL8 (100-
fold), IL6 (50-fold), TNFα (100-fold), and CCL2 (100-fold) in
the uterus (Supplementary Figure 11). The uterine abundance
of contraction associated gap junction protein Connexin-
43 (GJA1) mRNA also increased after LPS (40-fold) in the
uterus (Supplementary Figure 11). In contrast to effects in
the fetal membranes and AF, TNF blockade did not decrease
mRNA for inflammatory mediators or Connexin-43 in the
uterus (Supplementary Figure 11), suggesting that effect of
Adalimumab is limited to the feto-maternal interface.
Adalimumab Partially Blocked
LPS-Induced Cytokine Increases in Fetal
Plasma
Consistent with a lack of significant changes in the gene
expression profiles of maternal blood neutrophils in the various
experimental groups, the inflammation was almost entirely
localized to the intrauterine compartment since there were
no changes in plasma cytokines of dams injected with IA
LPS (except modest increases in plasma IL-6 and IL-1ra), and
plasma cytokines during IUI were ∼3-log fold lower (Figure 8)
compared to AF values. In contrast to maternal blood, fetal
plasma levels for IL-6, IL-12p40, IL-1β, CCL2/MCP1, IL-10,
GM-CSF, IL-1ra, but not IL-8/CXCL8 increased significantly
with LPS-exposure (Figure 8) and Adalimumab significantly
decreased LPS-induced IL-6 and IL-12p40 levels, but did not
change IL-1β, IL-8, CCL2/MCP1, and IL1-ra with non-significant
decreases in GM-CSF and IL-10 levels (Figure 8).
DISCUSSION
The intrauterine space at the maternal-fetal interface has
several compartments: fetal membranes (comprising amnion,
chorion, decidua parietalis), amniotic fluid, uterus, and the
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FIGURE 5 | Adalimumab decreased inflammation in the chorioamnion-decidua tissue. Extraplacental chorion-amnion-decidua parietalis tissue (fetal membranes) was
used. Expression of cytokine mRNAs by qPCR (Taqman probes) in the fetal membranes showed increased cytokines/chemokines after LPS, which was decreased
after Adalimumab. Average mRNA values are fold increases over the average value for control after internally normalizing to the housekeeping 18S RNA (Ctrl n =
14–15; LPS n = 13; Adalimumab n = 6). Data are mean ± SEM, *p < 0.05 vs. controls (Mann–Whitney U-test).
placenta (comprising villous placenta, decidua basalis, and
amnion-chorion). Although the fetal membranes are recognized
to play an important role in IUI (24), mechanisms of
immune cell activation in different intrauterine compartments
during infection are poorly understood. Using our previously
characterized model of IUI in preterm pregnant rhesus macaques
(8, 10). We now demonstrate that inhibition of TNF-signaling
reduces LPS-induced inflammation in all the intrauterine sub-
compartments with the exception of the uterus. The phenotype as
well as the function of neutrophils, the most abundant immune
cells at the maternal-fetal interface during IUI, has not been well-
characterized. Our results identify differences in gene expression
profiles between neutrophils found in maternal blood and those
residing in the chorio-decidua at baseline. Furthermore, in the
setting of IUI chorio-decidua neutrophils acquire a classic pro-
inflammatory gene expression profile (25) that is largely TNF-
signaling dependent. In summary, these studies improve our
understanding of the role of TNF-signaling plays in mediating
IUI and neutrophil regulation.
Among the different causes of preterm labor (PTL), IUI is
the best characterized both clinically and experimentally (3).
Although in our model PTL was not observed in any animal,
our focus was to identify early mechanisms of IUI that may
subsequently lead to PTL and hence we used a short LPS-
exposure interval of 16 h. In catheterized rhesus macaques,
PTL was reported with a variety of stimuli both from Gram
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FIGURE 6 | Signaling in amnion: Induction of LPS-induced pro-inflammatory cytokines and neutrophil chemoattractant is TNF-dependent. Amnion was physically
separated from chorion and decidua parietalis, and expression of cytokine mRNAs by quantitative PCR (Taqman probes) is shown. Intraamniotic LPS induced IL1β,
IL6, IL8/CXCL8 TNFα, CCL2/MCP1, and CSF3. All LPS-induced cytokine/chemokine mRNAs were inhibited by Adalimumab. Average mRNA values are fold
increases over the average value for control after internally normalizing to the housekeeping 18S RNA (Ctrl n = 3–17; LPS n = 7–16; Adalimumab n = 5–10). Data are
mean ± SEM, *p < 0.05 between comparators (Mann–Whitney U-test).
negative and positive organisms within 3d exposure (26, 27).
However, in our model we did not observe PTL with IA LPS
even after a 5day exposure despite a higher LPS dose than what
has been reported (Kallapur, 2019, unpubl. data). The observed
peak AF levels of TNFα and IL-6 in our studies were similar
to previously published data, however the PGF2α and IL-1β
levels were lower compared to the Boldenow et al. (27) and
Adams Waldorf et al. (26) studies. Thus, the discrepancy in
the observed results, presence or absence of preterm labor, may
be due to the differences in the experimental animal model
(e.g., indwelling catheters in the previous study compared to
no instrumentation in our study) or the net lower load of
some inflammatory mediators in our study. According to a
multi-center biomarker study of IUI, when compared to human
data, the IL-6 levels in the AF in our study would be categorized
as “severe inflammation” (28). Contrary to our data, studies in
mice did not show a benefit to neutrophil depletion in protecting
against LPS induced PTL (29, 30). However, these mice had
increased systemic concentrations of myeloid hematopoietic
progenitors and myelopoietic cytokines G-CSF, IL-23, and IL-
17 (31), presumably due to a “neurostat” mechanism sensing
neutrophil depletion. Clinical human studies clearly definitively
demonstrate that IUI increases the risk for PTL, however PTL is
not an invariable consequence of IUI (28).
Leukocytes comprise about 70% of all chorio-decidua cells
in the third trimester in both humans and rhesus macaques
(10). During LPS-induced IUI, neutrophils are the immune
subtype infiltrating the chorio-decidua and the amniotic fluid.
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FIGURE 7 | Adalimumab decreased intrauterine inflammation in amniotic fluid. (A) Cytokine and prostaglandins concentrations were measured in amniotic fluid by
multiplex ELISA. IL-1β, IL-6, IL-8/CXCL8, TNFα, CCL2/MCP1, CCL4/MIP1β, IL-1ra, IL-10, but not GM-CSF, PGF2α and PGE2 were significantly decreased upon
Adalimumab treatment. (B) Adalimumab decreased frequency of neutrophils in amniotic fluid. Data are mean ± SEM, *p < 0.05 vs. controls (Ctrl n = 17–25; LPS
n = 16–19; Adalimumab n = 11; Mann–Whitney U-test).
Indeed, there were no changes in the frequency of T cell,
NK cells, iNKT cells in the chorio-decidua after LPS in
our model. Recently, Tong et al. reported that induction of
neutrophil activation and Neutrophil Extracellular Trap (NET)
release is mediated at least in part by fetal membrane-derived
TNFα (11). We observed that the inhibition of TNF-signaling
decreased LPS-induced neutrophil counts by 80% in the chorio-
decidua and by 50% in the amniotic fluid. Based on our
SNP analyses, chorio-decidua neutrophils are almost entirely
of maternal origin. Prior studies addressing this question
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FIGURE 8 | Adalimumab decreased partially inflammation in fetal plasma. Cytokine concentrations were measured in maternal and fetal plasma by multiplex ELISA.
There was a minimal increase in cytokines in maternal plasma after IA LPS. In the fetal plasma, Adalimumab significantly decreased LPS-induced IL-6, and IL12p40,
but not IL-8/CXCL8, IL-1β, CCL2/MCP1, IL10, GM-CSF, and IL-1ra (Maternal plasma: Ctrl n = 15; LPS n = 15–18; Adalimumab n = 11; Fetal plasma: Ctrl
n = 19–26; LPS n = 17–18; Adalimumab n = 11). M, Maternal; F, Fetal. Data are mean ± SEM, *p < 0.05 between comparators by Mann-Whitney U-test.
used X and Y chromosome differences between mother
and male fetuses. Notably, our results using divergence in
SNPs as a methodology allowed us to determine the genetic
origin of neutrophils regardless of fetal sex. Despite the
differences in methodology, our results are consistent with
previous studies demonstrating that neutrophils infiltrating
the chorio-decidua are largely of maternal origin (32, 33).
This is in contrast to the neutrophils in the amniotic fluid
that are largely of fetal origin (34), or mixed fetal/maternal
origin (35).
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In addition to inhibiting neutrophil recruitment, TNF-
blockade decreased LPS-induced production of reactive oxygen
species, CD63/CD16 expression on neutrophils. CD63 is critical
to processing and secretion of neutrophil elastase (21). CD16
expression is induced by TNFα and mediates phagocytosis of
immune complexes (22). We previously reported that chorio-
decidua neutrophils are a major source of TNFα and CXCL8/IL-8
at the maternal-fetal interface (8, 10) and placentally-derived IL-
8 efficiently activates neutrophils and triggers NET formation
in a paracrine manner (36). Thus, our results demonstrate that
TNF-signalingmediates both neutrophil recruitment and a broad
program of neutrophil activation at the maternal-fetal interface.
Compared to the circulating neutrophils, those found
in the chorio-decidua under homeostatic conditions had a
higher expression of genes mediating extracellular matrix
organization, angiogenesis, cell migration, and regulation of
apoptotic processes and lower expression of genes involved
in the inflammatory pathways such as TLR signaling and
type I interferon signaling pathways. These findings are in
line with recent data showing striking differences between
the transcriptome of choriodecidua and maternal circulating
leukocytes (37). Although the results seem counter-intuitive
to the generally held notion that tissue neutrophils are pro-
inflammatory, placenta neutrophils can sub-serve homeostatic
functions and several studies report regulatory functions for
these neutrophils (38–40). Consistent with increased VEGFA
expression in the neutrophils from chorio-decidua compared
to blood in our study, other authors reported pro-angiogenic
neutrophils in normal 1st and 2nd trimester human decidua
basalis (41, 42). Based on peak neutrophil influx after the onset
of normal labor, post-partum uterus/decidua matrix remodeling
and wound healing function has been attributed to decidua
neutrophils (13, 43–45). Thus, our data support the concept of
neutrophil heterogeneity and a role in tissue homeostasis at the
maternal-fetal interface similar to that for other tissues (25, 46).
Two major changes were evident in chorio-decidua
neutrophils during LPS-induced IUI. First, neutrophil numbers
increased ∼10-fold becoming the most abundant decidua
cell-type. The gene expression profile within neutrophils also
changed from homeostatic to a pro-inflammatory phenotype,
consistent with a massive accumulation of activated neutrophils
at the maternal-fetal interface. Secondly, inhibition of TNF-
signaling in the chorio-decidua neutrophils was associated
with global changes in gene-expression during IUI. Of the
325 LPS-induced genes (>4-fold), approximately 80% were
down-regulated by Adalimumab. Major LPS-induced pathways
(representative gene) that were downregulated by Adalimumab
included NFkB signaling (IL6), TLR-signaling (IL1), oxidative-
burst (MPO), and neutrophil mediated innate immunity (LCN2).
LPS-induced genes not affected by Adalimumab include negative
regulators of cytokine signaling (SOCS3, CISH). Of note, these
results were validated by qPCR of selected key genes. Recently,
Tamassia et al. reported that the use of Adalimumab decreased
the production of IL-23 protein as well as decreased levels of
IL12B and IL23A transcripts in TLR-8 activated neutrophils
(47). Indeed, the gene-expression profiling predicts a net effect
of potent anti-inflammatory action by Adalimumab.
Consistent with our neutrophil-specific gene expression
data, Adalimumab decreased LPS-induced increases in the AF
levels of IL-6 and other cytokines; chorio-decidua mRNAs
expression of cytokines/chemokines; and fetal plasma IL-6 and
IL-12p40 levels. However, AF levels of prostaglandins (PGs)
and uterus tissue mRNAs cytokines were unchanged. IL-6 and
PGs are validated biomarkers of inflammation that mediate
preterm labor (48–50). In rodent models of IUI that involve
neutrophil influx into the placenta, TNF-blockade decreased
adverse pregnancy outcomes (51, 52). Consistent with this, a
small human study demonstrated that TNF-blockade improves
pregnancy outcomes in women with recurrent spontaneous
abortions (53). Thus, TNF-signaling appears to be important
in mediating IUI triggered by multiple different etiologies.
Furthermore, in our current study, decreased inflammatory
signaling in the neutrophils was associated with a reduction
of inflammation in multiple maternal-fetal compartments with
the exception for the uterus where TNF-blockade did not
decrease LPS-induced inflammation. The reasons for lack of
efficacy in uterus is not clear but possibilities include uterus
inflammation being regulated by other mediators such as
IL-6. It is also possible that the kinetics of inflammation
in the uterus may be different and our study evaluating
only one time point of exposure may have missed any
beneficial effects.
Other limitations of our study also have to be considered.
Firstly, although in our model of IUI neutrophils represent
the majority of leukocytes at the feto-maternal interface,
we did not investigate the contribution of other cells to
the inflammatory process, in particular macrophages. In fact,
we have previously shown that TNFα producing decidua
macrophage numbers do increase during IUI (10). In another
recent study, Doster et al. demonstrated that in response to
GBS infection placental macrophages can produce extracellular
traps, similar to the NETs produced by neutrophils (54).
Furthermore, other cytokines and cells (both immune cells
and resident cells) may play an important role in the setting
of IUI. Secondly, we did not observe preterm labor/birth
in our study. TNF-inhibition may not dampen inflammation
induced by live organisms including GBS or conditions
that may cause PTB. Thirdly, the route of injection of
Adalimumab (i.e., s.c. + IA) used in our model is not easily
feasible in the clinical setting and it will be important to
understand whether subcutaneous administration alone can
dampen the inflammation.
Amnion epithelium is strategically located at the maternal-
fetal interface and due to its contact with the AF, it is in an
ideal position to sense inflammatory mediators. We previously
reported that the amnion tissue expresses neutrophil-attracting
chemokines during IUI in an IL1R-IRAK1 dependent manner
(10), and others have demonstrated that fetal membranes
can recruit and activate neutrophils (9). Here, we show that
amnion expression of neutrophil chemokines is also TNF-
dependent. IL1 inhibition has overlapping results compared
to TNF inhibition in the same rhesus macaque model of
LPS-induced IUI (10, 11). However, a notable difference is
inhibition of LPS-induced AF PGE2 levels with IL1-blockade
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FIGURE 9 | Model for pathogenesis of intrauterine infection/inflammation. Representative cells in the different tissue layers of fetal membrane are shown. The left
panel in figure depicts normal pregnancy and the right panel shows changes during IUI. Inflammatory products and microbial products (red dots) in the amniotic fluid
and chorio-decidua activate the amnion, resulting in the release of leukocyte chemoattractants in a TNF-dependent manner. Based on a previous study, IL-1 signaling
also inhibits multiple pathways in IUI (10). Leukocytes accumulate at chorio-decidua junction, get activated, and greatly amplify the inflammation at the maternal-fetal
interface possibly interacting with each other and resident cells.
but not TNF inhibition. Taken together, both IL1- signaling
and TNF-signaling appear to be independently important
in the IUI network induced by LPS. Additionally, in the
present study, we also were able to demonstrate that the TNF
inhibition specifically decreased several inflammatory pathways
in the chorio-decidua neutrophils. Together with previous
literature, our results suggest a model for the pathogenesis
of intrauterine inflammation (Figure 9), proposing a key role
for both TNF- and IL1- signaling in mediating the initiation,
amplification of inflammation, and regulating recruitment and
activity of neutrophils and other leukocytes at the maternal-
fetal interface. The results also raise the prospect of utility
of specific cytokine blockade as a potential strategy for
intrauterine inflammation.
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